Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1676 to 1700 of about 5940

Previous 25

Website Changes

08/18/2016

Tamoxifen Induces Cytotoxic Autophagy in Glioblastoma.

08/18/2016

Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.

08/18/2016

Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.

08/16/2016

Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13

08/13/2016

MANY CANCER PATIENTS MUST FACE BANKRUPTCY—OR DIE

08/10/2016

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

08/10/2016

Call for chefs to enter Flo’s Chili Cook-Off

07/26/2016

NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma

07/26/2016

International Study Finds Effective, Less Toxic Way to Treat Brain Tumors

07/26/2016

International Study Finds Effective, Less Toxic Way to Treat Brain Tumors

07/26/2016

Musella Foundation awards $149,992 in 3 brain tumor research grants.

07/26/2016

Musella Foundation Co-payment Assistance Program is now closed to new patients

07/25/2016

NCCN updated CNS cancer treatment guidelines to include Optune

07/25/2016

Musella Foundation Co-payment Assistance Program about to close to new patients

07/23/2016

DelMar Pharmaceuticals Announces Presentation at the European Association of Neuro-Oncology (EANO) Annual Meeting in October 2016

07/23/2016

Local Biotech Company Develops Therapy to Treat Brain Cancer for Extended Survival

07/21/2016

PD-1 blockade enhances the vaccination induced immune response in glioma

07/16/2016

Weaponizing human EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1) for 21st century cancer therapeutics

07/13/2016

Novocure Receives FDA Approval for Second Generation Optune System

07/13/2016

Musella Foundation Request for Donations!

07/06/2016

New microfluidic device offers means for studying electric field cancer therapy

07/05/2016

FDA Grants Accurexa Pre-IND Meeting for its ACX-31 Program in the Treatment of Brain Cancer

07/04/2016

Scientists just discovered we`ve been looking at cancer growth all wrong. This could change everything.

07/02/2016

Questions and Answers on the New Study Linking Cellphones and Cancer in Rats

06/29/2016

Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.

Our privacy / cookie policy has changed.
Click HERE to read it!